Actively Recruiting
Intestinal Microsporidiosis in French Heart Transplant Recipients (CARMIC)
Led by University Hospital, Clermont-Ferrand · Updated on 2025-07-01
39
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators propose to carry out a national retrospective study to collect epidemiological, biological, clinical and therapeutic data on microsporidiosis among heart transplant patients.
CONDITIONS
Official Title
Intestinal Microsporidiosis in French Heart Transplant Recipients (CARMIC)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Heart transplant patients diagnosed with intestinal microsporidiosis
- Diagnosis made before December 31, 2024 in France (metropolitan France and overseas territories)
You will not qualify if you...
- Patient opposition
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU Gabriel Montpied
Clermont-Ferrand, France, 63000
Actively Recruiting
Research Team
L
Lise Laclautre
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here